跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 23,739 条关于
“differentiated thyroid carcinoma”
全部
23,739
临床试验
19,775
药物
144
机构
22
资讯
3,798
去年
Immunotherapy Combination Shows Promise in Anaplastic Thyroid Carcinoma
去年
Nivolumab and Ipilimumab Show Promise in Aggressive Thyroid Carcinoma Subtypes
3年前
European Regulators Recommend Cabometyx for Radioactive Iodine-Refractory Thyroid Cancer Based on 78% Reduction in Disease Progression
去年
Comprehensive Genomic Analysis Reveals Key Metastatic Pathways and Drug Targets in Thyroid Cancer
去年
Targeted Therapy and Immunotherapy Combination Shows Promise in Anaplastic Thyroid Carcinoma
去年
Targeted Therapy and Immunotherapy Combination Shows Promise in Anaplastic Thyroid Carcinoma
去年
PD-1/PD-L1 Inhibitors Show Promise in Thyroid Cancer Treatment Through Combination Strategies
2个月前
Vivos Receives FDA IDE Approval for First-in-Human RadioGel Trial in Non-Resectable Papillary Thyroid Carcinoma
去年
Thyroid Cancer Pipeline Shows Robust Growth with 50+ Companies Developing Novel Therapies
去年
UK Phase III Trial Shows Low-Risk Thyroid Cancer Patients Can Safely Skip Radioiodine Ablation After Surgery
第 1 页，共 380 页
上一页
下一页
